Abstract
Paraoxonase (PON1) hydrolyzes a great number of toxic organophosphorus compounds (OP) and uncharged esters of acetic acid and aromatic alcohols. No selective substrate and no standard assay method exist for PON1. Therefore strong definition criteria have to be applied to distinguish PON1 from other OP-detoxicating enzymes. Activity ratios of phenylacetate vs. OP, EDTA-inhibition, calcium-stimulation and resistance to covalent OP-inhibition are the criteria to identify PON1. PON1 is exclusively found in mammals and is synthesized by the liver. Plasma PON1 is bound to α-lipoproteins. Different mammalian species show great variations concerning their mean as well as their individual PON 1-activities. PON-activity in vivo is influenced by hormones and by diet.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Adie PA (1956) The purification of sarinase from bovine plasma. Canad J Biochem 34: 1091–1094
Aldridge WN (1953) An enzyme hydrolyzing diethyl p-nitrophenyl phosphate (E600) and its identity with the A-esterase of mammalian sera. Biochem J 53: 117–124
Aldridge WN (1954) Some esterases of the rat. Biochem J 57: 692–702
Augustinsson KB (1954) The enzymic hydrolysis of organophosphorus compounds. Biochim Biophys Acta 13: 303–304
Augustinsson KB (1959) Electrophoresis studies on blood plasma esterases. I. Mammalian plasmata. Acta Chem Scand 13: 571–592
Augustinsson KB, Heimbuerger G (1954) Enzymatic hydrolysis of organophosphorus compounds. IV. Specificity studies. Acta Chem Scand 8: 1533–1541
Augustinsson KB, Henricson B (1965) Effect of castration and of testosterone on arylesterase activity and protein content of blood plasma in male dogs. Acta endocr 50: 145–154
Björklund B, Paulsson JE, Ekberg S (1962) Curtain electrophoretic separation of phenylacetate hydrolyzing esterases of human serum. Demonstration of an EDTA-dependent enzyme. Proc Soc Exp Biol Med 110: 458–463
Brealey CJ, Walker CH, Baldwin BC (1980) A-esterase activities in relation to the differential toxicity of pirimiphosmethyl to birds and mammals. Pesticide Sci 11: 546–554
Choi SS, Forster TL (1967) Purification of bovine plasma arylesterase. J Dairy Sci 50: 1088–1091
Davies HG, Richter RJ, Keifer M, Broomfield CA, Sowalla J, Furlong CE (1996) The effect of human serum paraoxonase polymorphism is reversed with diazoxon, soman and sarin. Nat Genet 14: 334–336
De Bisschop HCJV, Quaeyhaegens FJL, Vanstockem MAH (1989) Degradation of soman in the sera of some large domestic animals. In: Reiner E, Aldridge WN, Hoskin FCG (eds) Enzymes hydrolyzing organophosphorus compounds. Ellis Horwood Publ, Chichester, pp 98–107
De Jong LPA, Van Dijk C, Benschop HP (1989) Stereoselective hydrolysis of soman and other chiral organophosphates by mammalian phosphorylphosphatases. In: Reiner E, Aldridge WN, Hoskin FCG (eds) Enzymes hydrolyzing organophosphorus compounds. Ellis Horwood Publ, Chichester, pp. 65–78
Eckerson HW, Romson J, Wyte C, LaDu BM (1983) The human serum paraoxonase polymorphism: Identification of phenotypes by their response to salts. Am J Hum Genet 35: 214–227
Erdoes EG and Boggs LE (1961) Hydrolysis of paraoxon in mammalian blood. Nature 190: 716–717
Erdoes EG, Debay CR, Westerman MP (1959) Activation and inhibition of the arylesterase of human serum. Nature 184: 430–431
Erdoes EG, Debay CR, Westerman MP (1960) Arylesterases in blood: effect of calcium and inhibitors. Biochem Pharmacol 5: 173–186
Feingold KR, Memon RA, Moser AG, Grunfeld C (1998) Paraoxonase activity in the serum and hepatic mRNA levels decrease during the acute phase response. Atherosclerosis 139: 307–315
Forte TM, Oda MN, Knoff L, Frei B, Suh J, Harmony JAK, Stuart WD, Rubin EM, Dominic SN (1999) Targeted disruption of the murine lecithin: cholesterol acyltransferase gene is associated with reductions in plasma paraoxonase and platelet-activating factor acetylhydrolase activities but not in apolipoprotein J concentration. J Lipid Res 40: 1276–1283
Furlong CE, Li WF, Costa LG, Richter RJ, Shih DM, Lusis AJ (1998) Genetically determined susceptibility to organophosphorus insecticides and nerve agents: PON1 polymorphism. Neurotoxicology 19: 645–650
Furlong CE, Richter RJ, Chapline C, Crabb JW (1991) Purification of rabbit and human serum paraoxonase. Biochemistry 30: 10133–10140
Furlong CE, Richter RJ, Seidel SL, Costa LG, Motulsky AG (1989) Spectrophotometric assays for the enzymatic hydrolysis of the active metabolites of chlorpyrifos and parathion by plasma paraoxonase/arylesterase. Anal Biochem 180: 242–247
Gan KN, Smolen A, Eckerson HW, La Du BN. Purification of human serum paraoxonase/ arylesterase. Evidence for one esterase catalyzing both activities (1990) Drug Metab Dispos 19: 100–106
Grimsley JK, Scholtz JM, Pace CN, Wild JR (1997) Organophosphorus hydrolase is a remarkably stable enzyme that unfolds through a homodimeric intermediate. Biochemistry 36: 14366–14374
Hannig C (2000) Untersuchung zum einfluß der paraoxonase-phänotypen A, AB und B auf die HDL-subfraktionen HDL2 und HDL3 im menschlichen serum. Thesis, Göttingen
Hassett C. Richter RJ, Humbert R, Chapline C, Crabb JW, Omiecinski CJ, Furlong CE (1991) Characterization of cDNA clones encoding rabbit and human serum paraxonase: The mature protein retains its signal sequence. Biochemistry 30: 10141–10149
Hoefermann D (1996) Arylesterase und HDL-cholesterin im serum von pferden. Thesis, Gießen
Humbert R, Adler DA, Disteche CM, Hassett C, Omiecinski CJ, Furlong CE (1993) The molecular basis of the human serum paraoxonase activity polymorphism. Nat Genet; 3: 73–76
Kitchen BJ, Masters CJ, Winzor DJ (1973) Effects of lipid removal on the molecular size and kinetic properties of bovine plasma arylesterase. Biochem J; 135: 93–99
Kluge K. Paraoxonase, Arylesterase und α-lipoproteine im serum verschiedener säugetiere. Thesis, Hannover 1992
Kuo CL, La Du BN (1995) Comparison of purified human and rabbit serum paraoxonases. Drug Metab Dispos 23: 935–944
La Du BN, Piko JI, Eckerson HW, Vincent-Viry M, Siest G (1986) An improved method for phenotyping individuals for the human serum paraoxonase/arylesterase polymorphism. Ann Biol Clin 44: 369–372
Lauwerys RR, Murphy SD (1969) Comparison of assay methods for studying O, O-diethyl, O-pnitrophenyl phosphate (paraoxon) detoxication in vitro. Biochem Pharmacol 18: 789–800
Le Jeune KE, Wild JR, Russell AJ (1998) Nerve agents degraded by enzymatic foams. Nature 395: 27–28
Li WF, Matthews C, Disteche CM, Costa LG, Furlong CE (1997) Paraoxonase (PON1) gene in mice: sequencing, chromosomal localization and developmental expression. Pharmacogenetics 7: 137–144
Losch K (1983) Untersuchung über die phosphorylphosphatase“paraoxonase”. Nachweis und kinetik in organen verschiedener wirbeltiere. Thesis, Göttingen
McCracken, Blain PG, Williams FM (1993) Human xenobiotic metabolizing esterases in liver and blood. Biochem Pharmacol 46: 1125–1129
Mackness M, Bouiller A, Hennuyer N, Mackness B, Hall M, Tailleux A, Duriez P, Delfly B, Durrington P, Fruchart JC, Duverger N, Caiilaud JM, Castro G (2000) Paraoxonase activity is reduced by a proatherosclerotic diet in rabbits. Biochem Biophys Res Comm 269: 232–236
Mackness B, Durrington PN, Mackness MI (1998) Lack of protection against oxidative modification of LDL by avian HDL. Biochem Biophys Res Comm 247: 443–446
Mackness, MI, Hallam SD, Peard T, Warner S, Walker CH (1985) The separation of sheep and human serum“A”-esterase activity into the lipoprotein fraction by ultracentrifugation. Comp Biochem Physiol 82B. 675–677
Mackness M, Thompson HM, Hardy AR, Walker CH (1987) Distinction between“A”-esterases and arylesterase. Biochem J 245: 293–296
Main AR (1960a) The purification of the enzyme hydrolyzing diethyl-p-nitrophenyl phosphate (paraoxon) in sheep serum. Biochem J 74: 10–20
Main AR. The differentiation of the A-type esterases in sheep serum. Biochem J (1960b) 75: 188–195
Mazur A (1946) An enzyme in animal tissues capable of hydrolyzing the phosphorus-fluorine bond of alkyl fluorophosphates. J Biol Chem 164: 271–289
Meyer I (1994) Untersuchungen zur polyethylenglykol-präzipitation der HDL2-und HDL3-assoziierten paraoxonase/arylesterase. Thesis, Göttingen
Monroy-Noyola A, Sogorb MA, Diaz-Alejo N, Niguez N, Barril J, Vicedo JL, Escudero MA, Vilanova E (1999) Dichlorophenyl phosphoramidates as substrates for avian and mammalian liver phosphotriesterases: activity levels, calcium dependence and stereospecifýcity. Chem Biol Interact 119/120: 257–262
Mounter LA (1955) The complex nature of dialkylfluorophosphatases of hog and rat liver and kidney. J Biol Chem 215: 705–711
Ozols J (1999) Isolation and complete covalent structure of liver microsomal paraoxonase. Biochem J 338: 265–272
Pla A, Johnson MK (1989) Comparison of degradation of various organophosphorus compounds by rat tissues“in vitro”. In: Reiner E, Aldridge WN, Hoskin FCG (eds) Enzymes hydrolyzing organophosphorus compounds. Ellis Horwood Publ, Chichester,. pp 118–127
Playfer JR, Eze LC, Bullen MF, Evans DAP (1976) Genetic polymorphism and interethnic variability of plasma paraoxonase activity. J Med Genet 13: 337–342
Primo-Parmo SL, Sorenson RC, Teiber J, La Du BN (1996) The human serum paraoxonase /arylesterase gene (PON1) is one member of a multigene family. Genomics 33: 498–507
Reddy ST, Wadleigh DJ, Grijalva V, Ng C, Hama S, Gangopadhya A, Shih DM, Lusis AJ, Navab M, Fogelman AM (2001) Human paraoxonase-3 is an HDL-associated enzyme not regulated by oxidized lipids. Arterioscler Thromb Vasc Biol 21: 542–547
Rodrigo L, Gil F, Hernandez AF, Marina A, Vazquez J, Pla A (1997) Purification and characterization of paraoxon hydrolase from rat liver. Biochem J 321: 595–601
Roeckseisen M (1992) Paraoxonase, aiylesterase und high-density-lipoproteine im menschlichen serum. Thesis, Göttingen
Schilling P (1982) Untersuchungen zur enzymatischen wntgiftung von organophosphaten mit immobilisierter paraoxonase aus kaninchenserum. Thesis, Göttingen
Schirrmacher K (1999) Einfluß der hormonellen antikonzeption und der postmenopausalen hormonsubstitution auf lipoproteine hoher dichte (HDL). Bedeutung des genetischen polymorphismus der HDL-paraoxonase im serum. Thesis, Göttingen
Severin RM (1997) Paraoxonase/arylesterase in serum und leber von kaninchen und rindern. vergleich mit den HDL-paraoxonase/arylesterase-isotypen A, AB und B des menschen. Thesis, Göttingen
Shih DM, Gu L, Hama S, Xia YR, Navab M, Fogelman AM, Lusis AJ. (1996) Genetic-dietary regulation of serum paraoxonase expression and its role in atherogenesis in a mouse model. J Clin Invest 97: 1630–1639
Shih DM, Gu L, Xia YR, Navab M, Li WF, Hama S, Castellani LW, Furlong CE, Costa LG, Fogelman AM, Lusis AJ (1998) Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis. Nature 394: 284–287
Smolen A, Eckerson HW, La Du BN (1982) Purification of arylesterases A and B from human serum. Am J Hum Genet 34: 36A
Sorenson RC, Bisgaier CL, Aviram M, Hsu C, Billecke S, La Du BN (1999) Human serum paraoxonase/arylesterases retained hydrophobic N-terminal leader sequence associates with HDLs by binding phospholipides. Apolipoprotein A-I stabilizes activity. Aiterioscler Thromb Vasc Biol 19: 2214–2225
Sorenson RC, Primo-Parmo SL, Camper SA, La Du BN (1995) The genetic mapping and gene structure of mouse paraoxonase/arylesterase. Genomics 30: 431–438
Tanaka-Kawai H, Yomoda S (1993) Molecular weight and substrate characteristics of human serum aiylesterase following purification by immuno-affinity chromatography. Clin Chim Acta 215: 127–138
Welling W, Blaakmeer P, Vink GJ, Voerman S (1970) In vitro hydrolysis of paraoxon by parathion resistant houseýlies. Pestic Biochem Physiol 1: 61–70
Whitehouse LW, Ecobichon DJ (1975) Paraoxon formation and hydrolysis by mammalian liver. Pestic Biochem Physiol 5: 314–322
Wigand KD (1975) Über die Phosphorylphosphatase und über Phosphoesterasen aus Escherichia coli-untersuchung mit der gelfiltration und der freien präparativen isoelektrischen fokussierung. Thesis, Göttingen
Zech R, Zuercher K (1974a) Organophosphate splitting serum enzymes in different mammals. Comp Biochem Physiol 48B. 427–433
Zech R, Zuercher K (1974b) Die Hemmung der Phosphorylphosphatase aus Kaninchenserum Arzneim-Forsch (Drug Res) 24: 337–340
Zech R, Reinhardt HG, Riexinger S, Reif R, Chemnitius JM. Substrate specificity and inhibition of organophosphorus compounds by rat tissues“in vitro”. In: Reiner E, Aldridge WN, Hoskin FCG (eds) Enzymes hydrolyzing organophosphorus compounds. Ellis Horwood Publ, Chichester, pp 108–117
Zech R, Roeckseisen M, Kluge K, Dewald K, Armstrong VW, Chemnitius JM (1993) Lipoproteins and hydrolysis of organophosphorus compounds. Chem Biol Interact 87: 85–94
Zech R, Severin RM, Chemnitius JM, Nebendahl K (1999) Paraoxonase polymorphism in rabbits. Chem Biol Interact; 119/120: 283–288
Zimmerman JK, Brown TM (1986) Partial purification of rabbit serum arylester hydrolase. J Agric Food Chem 34: 516–530
Zuercher K (1971) Über die enzymatische Hydrolyse von Organophosphaten. Thesis, Göttingen
Zimmerman JK, Brown TM (1986) Partial purification of rabbit serum arylester hydrolase. J Agric Food Chem 34: 516–530
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2002 Springer Science+Business Media New York
About this chapter
Cite this chapter
Zech, R., Chemnitius, J.M. (2002). PON1 in Different Species. In: Costa, L.G., Furlong, C.E. (eds) Paraoxonase (PON1) in Health and Disease. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-1027-7_7
Download citation
DOI: https://doi.org/10.1007/978-1-4615-1027-7_7
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-5358-4
Online ISBN: 978-1-4615-1027-7
eBook Packages: Springer Book Archive